On Friday, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) opened lower -3.34% from the last session, before settling in for the closing price of $11.08. Price fluctuations for RCKT have ranged from $10.07 to $31.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 3.95% at the time writing. With a float of $98.21 million, this company’s outstanding shares have now reached $106.34 million.
Let’s look at the performance matrix of the company that is accounted for 268 employees. In terms of profitability, gross margin is 5.46%, operating margin of -2655.06%, and the pretax margin is -2502.71%.
Rocket Pharmaceuticals Inc (RCKT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Rocket Pharmaceuticals Inc is 7.64%, while institutional ownership is 85.04%. The most recent insider transaction that took place on Jan 23 ’25, was worth 9,301. Before that another transaction happened on Nov 21 ’24, when Company’s insider sold 1,224 for $13.05, making the entire transaction worth $15,978. This insider now owns 49,310 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.86% during the next five years compared to -9.09% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Check out the current performance indicators for Rocket Pharmaceuticals Inc (RCKT). In the past quarter, the stock posted a quick ratio of 6.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.75, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.23 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) saw its 5-day average volume 1.48 million, a negative change from its year-to-date volume of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 43.98%. Additionally, its Average True Range was 0.74.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 5.36%, which indicates a significant decrease from 19.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.37% in the past 14 days, which was higher than the 58.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.66, while its 200-day Moving Average is $18.69. Nevertheless, the first resistance level for the watch stands at $11.11 in the near term. At $11.51, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.75. If the price goes on to break the first support level at $10.47, it is likely to go to the next support level at $10.23. Assuming the price breaks the second support level, the third support level stands at $9.83.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
There are currently 91,157K shares outstanding in the company with a market cap of 1.14 billion. Presently, the company’s annual sales total 0 K according to its annual income of -245,600 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -66,720 K.
